Keywords: PES، پکت لیتکسل، استنت (ها); BA, balloon angioplasty; BMS, bare-metal stent(s); CB, cutting balloon angioplasty; CCS, Canadian Cardiovascular Society; EES, everolimus-eluting stent(s); ISR, in-stent restenosis; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); TIMI,
مقالات ISI PES، پکت لیتکسل، استنت (ها) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents : Final Results From the SPIRIT III Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patien
Keywords: PES، پکت لیتکسل، استنت (ها); coronary artery disease; drug-eluting stent(s); in-stent restenosis; stent thrombosis; target vessel failureDES, drug-eluting stent(s); EES, everolimus-eluting stent(s); MACE, major adverse cardiac event(s); PES, paclitaxel-eluting stent(s); TLF, target l
Clinical Outcomes With Drug-Eluting and Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction : Evidence From a Comprehensive Network Meta-Analysis
Keywords: PES، پکت لیتکسل، استنت (ها); bare-metal stent(s); drug-eluting stent(s); meta-analysis; stent thrombosisBMS, bare-metal stent(s); CoCr-EES, cobalt-chromium everolimus-eluting stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); PCI, percutaneous coronary interventi
Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease : Final 3-Year Results of the SPIRIT Clinical Trials Program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of
Keywords: PES، پکت لیتکسل، استنت (ها); everolimus; paclitaxel; restenosisEES, everolimus-eluting stent(s); LAD, left anterior descending; MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); TLF, target lesion
SeQuent Please World Wide Registry : Clinical Results of SeQuent Please Paclitaxel-Coated Balloon Angioplasty in a Large-Scale, Prospective Registry Study
Keywords: PES، پکت لیتکسل، استنت (ها); drug-coated balloon; follow-up; in-stent restenosis; paclitaxelBMS, bare-metal stent(s); DES, drug-eluting stent(s); ISR, in-stent restenosis; MACE, major adverse cardiac event(s); PCB, paclitaxel-coated balloon; PES, paclitaxel-eluting stent(s); SES, sir
Coronary Endothelial Dysfunction Distal to Stent of First-Generation Drug-Eluting Stents
Keywords: PES، پکت لیتکسل، استنت (ها); angioscopy; drug-eluting stent; endothelial function; neointimaAch, acetylcholine; BMS, bare-metal stent(s); DES, drug-eluting stent(s); LST, late stent thrombosis; NTG, nitroglycerin; PES, paclitaxel-eluting stent(s); rs, Spearman rank correlation coeffi
Quantitative and Qualitative Changes in DES-Related Neointimal Tissue Based on Serial OCT
Keywords: PES، پکت لیتکسل، استنت (ها); neointima; optical coherence tomography; stentCSA, cross-sectional area; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); NIH, neointimal hyperplasia; OCT, optical coherence tomography; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting
Drug-eluting stent restenosis: Effect of drug type, release kinetics, hemodynamics and coating strategy
Keywords: PES، پکت لیتکسل، استنت (ها); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); SS, shear stressDrug-eluting stent; In-stent restenosis; Drug release; Shear stress; Polymer coating; Percutaneous coronary intervention
Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents : 2-Year Follow-Up From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV Trial
Keywords: PES، پکت لیتکسل، استنت (ها); angioplasty; prognosis; stentDES, drug-eluting stent(s); EES, everolimus-eluting stent(s); MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); TLF, target lesion failure; TLR, target lesion revascularizati
2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice : COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent
Keywords: PES، پکت لیتکسل، استنت (ها); drug-eluting stent; myocardial infarction; stent thrombosisCI, confidence interval; DAPT, dual antiplatelet therapy; EES, everolimus-eluting stent(s); MI, myocardial infarction; PES, paclitaxel-eluting stent(s); RR, relative risk; SES, sirolimus-eluting s
Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents : 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Cor
Keywords: PES، پکت لیتکسل، استنت (ها); drug-eluting stent(s); percutaneous coronary intervention; zotarolimusDES, drug-eluting stent(s); MACE, major adverse cardiac event(s); MI, myocardial infarction; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); TLR, target lesion revasc
Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents
Keywords: PES، پکت لیتکسل، استنت (ها); drug-eluting stent; malapposition; pathology; stent thrombosis; vascular responseBMS, bare-metal stent(s); DES, drug-eluting stent(s); LST, late stent thrombosis; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s)
Long-Term Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents for Coronary Revascularization
Keywords: PES، پکت لیتکسل، استنت (ها); coronary disease; drug-eluting stents; stent thrombosisCI, confidence interval; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio; MI, myocardial infarction; PES, paclitaxel-eluting stent(s); PS, propensity score; RR, relative
Impact of the Everolimus-Eluting Stent on Stent Thrombosis : A Meta-Analysis of 13 Randomized Trials
Keywords: PES، پکت لیتکسل، استنت (ها); drug-eluting stent; everolimus-eluting; stent thrombosisDAPT, dual-antiplatelet therapy; DES, drug-eluting stent(s); EE, everolimus-eluting; EES, everolimus-eluting stent(s); MI, myocardial infarction; PES, paclitaxel-eluting stent(s); SES, sirolimus-elut
Difference of Neointimal Formational Pattern and Incidence of Thrombus Formation Among 3 Kinds of Stents: An Angioscopic Study
Keywords: PES، پکت لیتکسل، استنت (ها); angioscopy; heterogeneity; neointimal dysfunction; stent; thrombusBMS, bare-metal stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s)
Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents : The ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) Study
Keywords: PES، پکت لیتکسل، استنت (ها); drug-eluting stent; in-stent restenosis; sirolimus; resistance; randomized trialDES, drug-eluting stent(s); ISAR, individualizable stent to abrogate restenosis; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); QCA, quantitative a
The Relationship and Threshold of Stent Length With Regard to Risk of Stent Thrombosis After Drug-Eluting Stent Implantation
Keywords: PES، پکت لیتکسل، استنت (ها); drug-eluting stent; stent length; stent thrombosisBMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; IQR, interquartile range; MI, myocardial infarction; PES, paclitaxel-eluting stent(s); PCI, percutaneous cor
Selection Criteria for Drug-Eluting Versus Bare-Metal Stents and the Impact of Routine Angiographic Follow-Up : 2-Year Insights From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
Keywords: PES، پکت لیتکسل، استنت (ها); acute myocardial infarction; angiography; bare-metal stent; drug-eluting stent; outcomesBMS, bare-metal stent(s); DES, drug-eluting stent(s); PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); RVD, reference vessel diameter; STEMI,
Increased Restenosis Rate After Implantation of Drug-Eluting Stents in Patients With Elevated Serum Activity of Matrix Metalloproteinase-2 and -9
Keywords: PES، پکت لیتکسل، استنت (ها); angioplasty; drug-eluting stents; restenosis; metalloproteinasesBMS, bare-metal stent(s); DES, drug-eluting stent(s); ISR, in-stent restenosis; MMP, matrix metalloproteinase; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); SES,
The Effect of Shear Stress on Neointimal Response Following Sirolimus- and Paclitaxel-Eluting Stent Implantation Compared With Bare-Metal Stents in Humans
Keywords: PES، پکت لیتکسل، استنت (ها); drug-eluting stent(s); neointimal thickness; paclitaxel; shear stress; sirolimus3D, 3-dimensional; BMS, bare-metal stent(s); DES, drug-eluting stent(s); IVUS, intravascular ultrasound; NT, neointimal thickness; PES, paclitaxel-eluting stent(s); SES, sirol
Influence of Sex on Long-Term Outcomes After Percutaneous Coronary Intervention With the Paclitaxel-Eluting Coronary Stent : Results of the “TAXUS Woman” Analysis
Keywords: PES، پکت لیتکسل، استنت (ها); coronary disease; drug-eluting stent(s); revascularization; sexBMS, bare-metal stent(s); DES, drug-eluting stent(s); MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); RVD, reference vessel diameter; TLR,
Impact of Stent Overlap on Angiographic and Long-Term Clinical Outcome in Patients Undergoing Drug-Eluting Stent Implantation
Keywords: PES، پکت لیتکسل، استنت (ها); coronary artery disease; drugs; overlap; restenosis; stentsBMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); MACE, major adverse cardiac events; MI, myocardial infarction; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluti
Heterogeneous Arterial Healing in Patients Following Paclitaxel-Eluting Stent Implantation : Comparison With Sirolimus-Eluting Stents
Keywords: PES، پکت لیتکسل، استنت (ها); angioscope; imaging; neointima; stentBMS, bare-metal stent(s); DES, drug-eluting stent(s); LL, late loss; LST, late stent thrombosis; NIC, neointimal coverage; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); YP, yellow plaques
Intravascular Ultrasound Results From the ENDEAVOR IV Trial : Randomized Comparison Between Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
Keywords: PES، پکت لیتکسل، استنت (ها); ultrasound; zotarolimus-eluting stent; coronary artery diseaseCSN, cross-sectional narrowing; DES, drug-eluting stent(s); ISA, incomplete stent apposition; IVUS, intravascular ultrasound; PES, paclitaxel-eluting stent(s); VI, volume index; ZES, zotarolimu
The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial
Keywords: PES، پکت لیتکسل، استنت (ها); percutaneous coronary intervention; ST-segment elevation myocardial infarction; drug-eluting stentsBMS, bare-metal stent(s); DES, drug-eluting stent(s); PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting sten
Late Clinical Events After Drug-Eluting Stents : The Interplay Between Stent-Related and Natural History-Driven Events
Keywords: PES، پکت لیتکسل، استنت (ها); angioplasty; coronary disease; drug-eluting stents; revascularizationARC, Academic Research Consortium; BMS, bare-metal stent(s); DES, drug-eluting stent(s); HR, hazard rate; MI, myocardial infarction; PES, paclitaxel-eluting stent(s); QWMI, Q-wave myocar
The Pre-Clinical Animal Model in the Translational Research of Interventional Cardiology
Keywords: PES، پکت لیتکسل، استنت (ها); pre-clinical study; animal model; cardiovascular interventionAS, aortic stenosis; CTO, chronic total occlusion; DES, drug-eluting stent(s); LAA, left arterial appendage; MI, myocardial infarction; MR, mitral regurgitation; PES, paclitaxel-eluting stent(s)
Drug-Eluting Stent Thrombosis: Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)
Keywords: PES، پکت لیتکسل، استنت (ها); BMS, bare-metal stent(s); DES, drug-eluting stent(s); LAD, left anterior descending artery; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); ST, stent thrombosis; STEMI, ST-segment elevation myocardial infarction
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Stent Implantation in Patients Taking Chronic Oral Anticoagulation
Keywords: PES، پکت لیتکسل، استنت (ها); AC, anticoagulation; AF, atrial fibrillation; BMS, bare-metal stent(s); INR, international normalized ratio; MACCE, major adverse cardiac and cerebrovascular events; MI, myocardial infarction; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent
Randomized Clinical Trials and Observational Studies: Guidelines for Assessing Respective Strengths and Limitations
Keywords: PES، پکت لیتکسل، استنت (ها); BMS, bare-metal stent(s); CABG, coronary artery bypass graft; CI, confidence interval; DES, drug-eluting stent(s); HRT, hormone replacement therapy; OR, odds ratio; OS, observational study/studies; PES, paclitaxel-eluting stent(s); PTCA, percutaneous tran
Six-Month Comparison of Coronary Endothelial Dysfunction Associated With Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent
Keywords: PES، پکت لیتکسل، استنت (ها); Ach, acetylcholine; ANOVA, analysis of variance; BMS, bare-metal stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s)
Chronic Arterial Responses to Overlapping Paclitaxel-Eluting Stents : Insights From Serial Intravascular Ultrasound Analyses in the TAXUS-V and -VI Trials
Keywords: PES، پکت لیتکسل، استنت (ها); BMS, bare-metal stent(s); CSA, cross-sectional area; DES, drug-eluting stent(s); EEM, external elastic membrane; IH, intimal hyperplasia (area); ISA, incomplete stent apposition; IVUS, intravascular ultrasound system; PES, paclitaxel-eluting stent(s); P&a
Differential Effects of Drug-Eluting Stents on Local Endothelium-Dependent Coronary Vasomotion
Keywords: PES، پکت لیتکسل، استنت (ها); BES, biolimus A9-eluting stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); QCA, quantitative coronary angiography; SES, sirolimus-eluting stent(s)
Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus : The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent
Keywords: PES، پکت لیتکسل، استنت (ها); BMS, bare-metal stent(s); DES, drug-eluting stent(s); MACE, major adverse cardiac events; MI, myocardial infarction; PES, paclitaxel-eluting stent(s); QCA, quantitative coronary angiography; SES, sirolimus-eluting stent(s); TLR, target lesion revasculariz
Clinical Efficacy of Drug-Eluting Stents in Diabetic Patients : A Meta-Analysis
Keywords: PES، پکت لیتکسل، استنت (ها); BMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); MACE, major adverse cardiac event; OR, odds ratio; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); RCT, randomized controlled trial; SES, sirolimus-e
Perioperative Management of Patients With Coronary Stents
Keywords: PES، پکت لیتکسل، استنت (ها); AMI, acute myocardial infarction; BMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s)
Effectiveness of Drug-Eluting Stents in Patients With Bare-Metal In-Stent Restenosis: Meta-Analysis of Randomized Trials
Keywords: PES، پکت لیتکسل، استنت (ها); BA, balloon angioplasty; BMS, bare-metal stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); TLR, target lesion revascularization
A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
Keywords: PES، پکت لیتکسل، استنت (ها); CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; MI, myocardial infarction; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s)
Late and Very Late Thrombosis of Drug-Eluting Stents: Evolving Concepts and Perspectives
Keywords: PES، پکت لیتکسل، استنت (ها); BMS, bare-metal stent(s); DES, drug-eluting stent(s); MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); ST, stent thrombosis
Impact of Vessel Size on Outcome After Implantation of Sirolimus-Eluting and Paclitaxel-Eluting Stents: A Subgroup Analysis of the SIRTAX Trial
Keywords: PES، پکت لیتکسل، استنت (ها); DES, drug-eluting stent(s); MACE, major adverse cardiac events; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); RVD, reference vessel diameter; SES, sirolimus-eluting stent(s); TLR, target lesion revascularization
Comparative Clinical Outcomes of Paclitaxel- and Sirolimus-Eluting Stents : Results From a Large Prospective Multicenter Registry—STENT Group
Keywords: PES، پکت لیتکسل، استنت (ها); MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); SAT, subacute stent thrombosis; SES, sirolimus-eluting stent(s); ST, stent thrombosis; TVR, target vessel revasculari
Thrombosis and Drug-Eluting Stents: An Objective Appraisal
Keywords: PES، پکت لیتکسل، استنت (ها); ARC, Academic Research Consortium; BMS, bare-metal stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); ST, stent thrombosis